L-arginine metabolism and its impact on host immunity against Leishmania infection
- PMID: 18040886
- PMCID: PMC2639710
- DOI: 10.1007/s12026-007-8012-y
L-arginine metabolism and its impact on host immunity against Leishmania infection
Abstract
Leishmaniasis is a vector-borne disease found in many countries worldwide. The causative agent of the disease, Leishmania spp., lives as an obligate intracellular parasite within mammalian hosts. Since tissue macrophages are major target cells for parasite replication, the outcome of infection depends largely on the activation status of these cells. L-arginine is a crucial amino acid required for both nitric oxide (NO)-mediated parasite killing and polyamine-mediated parasite replication. This review highlights the significance of L-arginine as a factor determining the outcomes of Leishmania infection in vitro and its influences on host immune responses in vivo. Various therapeutic approaches targeting L-arginine metabolic pathways during infections with Leishmania are also discussed.
Figures
References
-
- Bogitsh BJ, Carter CE, Oeltmann TN. Human Parastiology. 3rd ed. Elsevier Academic Press; Burlington: 2005. Blood and tissue protozoa I: hemaflagellates. pp. 101–14. Chapter 6.
-
- Moll H, Flohe S, Rollinghoff M. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. Eur J Immunol. 1995;25:693–9. - PubMed
-
- van Zandbergen G, Klinger M, Mueller A, Dannenberg S, Gebert A, Solbach W, Laskay T. Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J Immunol. 2004;173:6521–5. - PubMed
-
- Noel W, Raes G, Hassanzadeh GG, De Baetselier P, Beschin A. Alternatively activated macrophages during parasite infections. Trends Parasitol. 2004;20:126–33. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous